ZALTRAP (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the ZALTRAP drug offered from sanofi-aventis U.S. LLC. This Vascular Endothelial Growth Factor Inhibitor [EPC],Vascular Endothelial Growth Factor Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | ziv-aflibercept |
| SUBSTANCE NAME: | AFLIBERCEPT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Vascular Endothelial Growth Factor Inhibitor [EPC],Vascular Endothelial Growth Factor Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2012-08-03 |
| END MARKETING DATE: | 0000-00-00 |
ZALTRAP HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZALTRAP from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/4mL) |
| START MARKETING DATE: | 2012-08-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-5840_31d60114-8140-4427-a086-ee306d3bc458 |
| PRODUCT NDC: | 0024-5840 |
| APPLICATION NUMBER: | BLA125418 |
Other AFLIBERCEPT Pharmaceutical Manufacturers / Labelers:
